CHEBI ONTOLOGY - ANNOTATIONS
The Chemical Entities of Biological Interest (ChEBI) ontology is downloaded weekly from EMBL-EBI at http://www.ebi.ac.uk/chebi/ . The data is made available under the Creative Commons License (CC BY 3.0, http://creativecommons.org/licenses/by/3.0/ ). For more information see: Degtyarenko et al. (2008) ChEBI: a database and ontology for chemical entities of biological interest. Nucleic Acids Res. 36, D344–D350.
Term: chlorobenzoic acid
Accession: CHEBI:23134
browse the term
Definition: Any member of the class of benzoic acids in which the benzene ring is substituted by at least one chloro group.
Synonyms: related_synonym: chlorobenzoic acids
cyclic_relationship: is_conjugate_acid_of CHEBI:23133
G
Abcc2
ATP binding cassette subfamily C member 2
multiple interactions
ISO EXP
Furosemide promotes the reaction [ABCC2 protein affects the transport of estradiol-17 beta-glucuronide] [Furosemide results in increased activity of ABCC2 protein] promotes the reaction [Glucose results in increased secretion of S-(2,4-dinitrophenyl)glutathione]
CTD
PMID:12704183 PMID:19782883
NCBI chr 1:263,554,426...263,612,556
Ensembl chr 1:263,554,453...263,613,252
G
Abcc3
ATP binding cassette subfamily C member 3
multiple interactions
ISO
Furosemide inhibits the reaction [ABCC3 protein affects the transport of estradiol-17 beta-glucuronide]
CTD
PMID:12704183
NCBI chr10:82,047,308...82,116,928
Ensembl chr10:82,047,863...82,117,109
G
Abcc4
ATP binding cassette subfamily C member 4
increases export increases transport
ISO
ABCC4 protein results in increased export of Furosemide ABCC4 protein results in increased transport of Furosemide
CTD
PMID:17135398 PMID:17939016
NCBI chr15:103,695,415...103,927,980
Ensembl chr15:103,696,557...103,927,592
G
Adamts1
ADAM metallopeptidase with thrombospondin type 1 motif, 1
affects expression
EXP
Furosemide affects the expression of ADAMTS1 mRNA
CTD
PMID:16526316
NCBI chr11:25,342,119...25,350,938
Ensembl chr11:25,342,126...25,350,974
G
Agt
angiotensinogen
increases expression
ISO
Furosemide results in increased expression of AGT protein modified form
CTD
PMID:18081357
NCBI chr19:57,321,594...57,333,460
Ensembl chr19:57,321,640...57,333,433
G
Akt1
AKT serine/threonine kinase 1
affects phosphorylation
EXP
Furosemide affects the phosphorylation of AKT1 protein
CTD
PMID:17497460
NCBI chr 6:137,218,398...137,239,970
Ensembl chr 6:137,218,376...137,236,258
G
Alb
albumin
multiple interactions affects binding
ISO
[bucolome inhibits the reaction [Furosemide binds to ALB protein]] which affects the abundance of Furosemide; bucolome inhibits the reaction [Furosemide binds to ALB protein]
CTD
PMID:15640375
NCBI chr14:19,176,275...19,191,793
Ensembl chr14:19,176,277...19,191,863
G
Aldh1a1
aldehyde dehydrogenase 1 family, member A1
increases expression
EXP
Furosemide results in increased expression of ALDH1A1 mRNA
CTD
PMID:28138970
NCBI chr 1:238,222,689...238,264,381
Ensembl chr 1:238,222,521...238,264,330
G
Ang
angiogenin
affects expression
EXP
Furosemide affects the expression of ANG mRNA
CTD
PMID:16526316
NCBI chr15:28,022,926...28,028,636
G
Angpt2
angiopoietin 2
affects expression
EXP
Furosemide affects the expression of ANGPT2 mRNA
CTD
PMID:16526316
NCBI chr16:75,966,480...76,016,147
Ensembl chr16:75,966,352...76,016,195
G
Apaf1
apoptotic peptidase activating factor 1
affects expression
EXP
Furosemide affects the expression of APAF1 mRNA
CTD
PMID:17497460
NCBI chr 7:31,699,309...31,784,192
Ensembl chr 7:31,699,885...31,784,192
G
Aqp2
aquaporin 2
increases expression
EXP
Furosemide results in increased expression of AQP2 mRNA; Furosemide results in increased expression of AQP2 protein
CTD
PMID:17584643
NCBI chr 7:141,237,802...141,242,837
Ensembl chr 7:141,237,768...141,245,165
G
Arc
activity-regulated cytoskeleton-associated protein
affects expression
EXP
Furosemide affects the expression of ARC mRNA
CTD
PMID:17497460
NCBI chr 7:115,907,097...115,911,059
Ensembl chr 7:115,907,097...115,910,541
G
Arntl
aryl hydrocarbon receptor nuclear translocator-like
decreases secretion
ISO
ARNTL gene mutant form results in decreased secretion of Furosemide
CTD
PMID:27056296
NCBI chr 1:178,039,002...178,137,469
Ensembl chr 1:178,039,063...178,137,465
G
Atm
ATM serine/threonine kinase
affects expression
EXP
Furosemide affects the expression of ATM mRNA
CTD
PMID:17497460
NCBI chr 8:58,015,938...58,119,973
Ensembl chr 8:58,015,940...58,120,045
G
Atp6v1b1
ATPase H+ transporting V1 subunit B1
multiple interactions increases expression
EXP
[Furosemide co-treated with Amiloride] results in increased expression of ATP6V1B1 protein Furosemide results in increased expression of ATP6V1B1 protein
CTD
PMID:17311909
NCBI chr 4:115,417,100...115,435,754
Ensembl chr 4:115,416,580...115,437,206
G
Avpr2
arginine vasopressin receptor 2
increases expression
EXP
Furosemide results in increased expression of AVPR2 mRNA
CTD
PMID:17584643
NCBI chr X:156,889,006...156,892,707
Ensembl chr X:156,889,410...156,891,213
G
Bad
BCL2-associated agonist of cell death
affects expression
EXP
Furosemide affects the expression of BAD mRNA
CTD
PMID:17497460
NCBI chr 1:222,198,516...222,207,459
Ensembl chr 1:222,198,534...222,207,453
G
Bak1
BCL2-antagonist/killer 1
affects expression
EXP
Furosemide affects the expression of BAK1 mRNA
CTD
PMID:17497460
NCBI chr20:5,609,620...5,618,899
Ensembl chr20:5,609,625...5,618,260
G
Bax
BCL2 associated X, apoptosis regulator
affects expression
EXP
Furosemide affects the expression of BAX mRNA
CTD
PMID:17497460
NCBI chr 1:101,451,801...101,457,207
Ensembl chr 1:101,451,802...101,457,207
G
Bcl10
BCL10, immune signaling adaptor
affects expression
EXP
Furosemide affects the expression of BCL10 mRNA
CTD
PMID:17497460
NCBI chr 2:251,805,392...251,814,957
Ensembl chr 2:251,805,392...251,814,957
G
Bcl2
BCL2, apoptosis regulator
affects expression
EXP
Furosemide affects the expression of BCL2 mRNA
CTD
PMID:17497460
NCBI chr13:26,605,426...26,769,374
Ensembl chr13:26,605,426...26,769,374
G
Bcl2l10
BCL2 like 10
affects expression
EXP
Furosemide affects the expression of BCL2L10 mRNA
CTD
PMID:17497460
NCBI chr 8:82,288,705...82,294,750
Ensembl chr 8:82,288,705...82,294,744
G
Bcl2l11
BCL2 like 11
affects expression
EXP
Furosemide affects the expression of BCL2L11 mRNA
CTD
PMID:17497460
NCBI chr 3:120,726,906...120,764,192
Ensembl chr 3:120,726,906...120,764,192
G
Bcl2l2
Bcl2-like 2
affects expression
EXP
Furosemide affects the expression of BCL2L2 mRNA
CTD
PMID:17497460
NCBI chr15:33,543,774...33,549,165
Ensembl chr15:33,544,312...33,549,164
G
Bid
BH3 interacting domain death agonist
affects expression
EXP
Furosemide affects the expression of BID mRNA
CTD
PMID:17497460
NCBI chr 4:153,439,812...153,465,247
Ensembl chr 4:153,442,218...153,465,203
G
Bik
BCL2-interacting killer
affects expression
EXP
Furosemide affects the expression of BIK mRNA
CTD
PMID:17497460
NCBI chr 7:124,390,924...124,410,449
Ensembl chr 7:124,391,432...124,410,447
G
Birc2
baculoviral IAP repeat-containing 2
affects expression
EXP
Furosemide affects the expression of BIRC2 mRNA
CTD
PMID:17497460
NCBI chr 8:6,014,014...6,036,668
Ensembl chr 8:6,013,207...6,034,142
G
Birc5
baculoviral IAP repeat-containing 5
affects expression
EXP
Furosemide affects the expression of BIRC5 mRNA
CTD
PMID:17497460
NCBI chr10:106,856,097...106,864,419
Ensembl chr10:106,856,097...106,864,413
G
Birc6
baculoviral IAP repeat-containing 6
affects expression
EXP
Furosemide affects the expression of BIRC6 mRNA
CTD
PMID:17497460
NCBI chr 6:21,900,763...22,092,484
Ensembl chr 6:21,950,100...22,092,346
G
Bok
BCL2 family apoptosis regulator BOK
affects expression
EXP
Furosemide affects the expression of BOK mRNA
CTD
PMID:17497460
NCBI chr 9:100,829,593...100,840,498
Ensembl chr 9:100,829,552...100,840,504
G
Bsnd
barttin CLCNK type accessory subunit beta
decreases expression
EXP
Furosemide results in decreased expression of BSND mRNA
CTD
PMID:12759757
NCBI chr 5:126,071,849...126,080,647
Ensembl chr 5:126,071,846...126,080,698
G
Calb1
calbindin 1
increases expression
ISO
Furosemide results in increased expression of CALB1 mRNA; Furosemide results in increased expression of CALB1 protein
CTD
PMID:17652376
NCBI chr 5:29,538,380...29,562,774
Ensembl chr 5:29,538,380...29,562,773
G
Car2
carbonic anhydrase 2
decreases activity increases expression
ISO EXP
Furosemide results in decreased activity of CA2 protein Furosemide results in increased expression of CA2 mRNA
CTD
PMID:16858005 PMID:28138970
NCBI chr 2:88,097,740...88,112,868
Ensembl chr 2:88,097,720...88,113,029
G
Casp1
caspase 1
affects expression
EXP
Furosemide affects the expression of CASP1 mRNA
CTD
PMID:17497460
NCBI chr 8:2,605,743...2,614,637
Ensembl chr 8:2,604,962...2,614,631
G
Casp12
caspase 12
affects expression
EXP
Furosemide affects the expression of CASP12 mRNA
CTD
PMID:17497460
NCBI chr 8:2,658,892...2,686,160
Ensembl chr 8:2,659,865...2,686,160
G
Casp14
caspase 14
affects expression
EXP
Furosemide affects the expression of CASP14 mRNA
CTD
PMID:17497460
NCBI chr 7:13,938,376...13,944,286
Ensembl chr 7:13,938,302...13,945,130
G
Casp2
caspase 2
affects expression
EXP
Furosemide affects the expression of CASP2 mRNA
CTD
PMID:17497460
NCBI chr 4:71,652,358...71,670,228
Ensembl chr 4:71,652,354...71,670,239
G
Casp3
caspase 3
affects expression
EXP
Furosemide affects the expression of CASP3 mRNA
CTD
PMID:17497460
NCBI chr16:48,845,011...48,863,249
Ensembl chr16:48,845,012...48,863,204
G
Casp4
caspase 4
affects expression
EXP
Furosemide affects the expression of CASP4 mRNA
CTD
PMID:17497460
NCBI chr 8:2,616,391...2,651,682
Ensembl chr 8:2,635,851...2,651,652
G
Casp6
caspase 6
affects expression
EXP
Furosemide affects the expression of CASP6 mRNA
CTD
PMID:17497460
NCBI chr 2:235,341,326...235,353,715
Ensembl chr 2:235,341,365...235,353,967 Ensembl chr 2:235,341,365...235,353,967
G
Casp8
caspase 8
affects expression
EXP
Furosemide affects the expression of CASP8 mRNA
CTD
PMID:17497460
NCBI chr 9:65,614,142...65,662,624
Ensembl chr 9:65,614,142...65,662,106
G
Casp9
caspase 9
affects expression
EXP
Furosemide affects the expression of CASP9 mRNA
CTD
PMID:17497460
NCBI chr 5:160,356,211...160,373,774
Ensembl chr 5:160,355,833...160,373,778
G
Cd40
CD40 molecule
affects expression
EXP
Furosemide affects the expression of CD40 mRNA
CTD
PMID:17497460
NCBI chr 3:161,519,789...161,534,943
Ensembl chr 3:161,519,743...161,534,704
G
Cd70
Cd70 molecule
affects expression
EXP
Furosemide affects the expression of CD70 mRNA
CTD
PMID:17497460
NCBI chr 9:9,842,585...9,845,728
Ensembl chr 9:9,842,585...9,845,728
G
Cdh5
cadherin 5
decreases expression
EXP
Furosemide results in decreased expression of CDH5 mRNA
CTD
PMID:16526316
NCBI chr19:1,025,122...1,074,333
Ensembl chr19:1,023,683...1,074,365
G
Chek1
checkpoint kinase 1
affects expression
EXP
Furosemide affects the expression of CHEK1 mRNA
CTD
PMID:17497460
NCBI chr 8:39,181,162...39,201,588
Ensembl chr 8:39,181,163...39,243,882
G
Chek2
checkpoint kinase 2
affects expression
EXP
Furosemide affects the expression of CHEK2 mRNA
CTD
PMID:17497460
NCBI chr12:51,845,574...51,878,098
Ensembl chr12:51,845,796...51,877,624
G
Chga
chromogranin A
increases expression
EXP
Furosemide results in increased expression of CHGA mRNA
CTD
PMID:16526316
NCBI chr 6:126,434,226...126,445,569
Ensembl chr 6:126,434,226...126,445,568
G
Cidea
cell death-inducing DFFA-like effector a
affects expression
EXP
Furosemide affects the expression of CIDEA mRNA
CTD
PMID:17497460
NCBI chr18:63,082,861...63,108,450
Ensembl chr18:63,098,144...63,108,051
G
Cideb
cell death-inducing DFFA-like effector b
affects expression
EXP
Furosemide affects the expression of CIDEB mRNA
CTD
PMID:17497460
NCBI chr15:34,439,844...34,444,244
Ensembl chr15:34,439,876...34,444,244
G
Clcnka
chloride voltage-gated channel Ka
decreases expression
EXP
Furosemide results in decreased expression of CLCNKA mRNA
CTD
PMID:12759757
NCBI chr 5:159,931,497...159,946,483
Ensembl chr 5:159,931,511...159,946,446
G
Col18a1
collagen type XVIII alpha 1 chain
decreases expression
EXP
Furosemide results in decreased expression of COL18A1 mRNA
CTD
PMID:16526316
NCBI chr20:12,225,202...12,332,858
Ensembl chr20:12,225,202...12,332,858
G
Cradd
CASP2 and RIPK1 domain containing adaptor with death domain
affects expression
EXP
Furosemide affects the expression of CRADD mRNA
CTD
PMID:17497460
NCBI chr 7:36,395,665...36,408,588
Ensembl chr 7:36,395,665...36,408,588
G
Csf3
colony stimulating factor 3
increases expression
EXP
Furosemide results in increased expression of CSF3 mRNA
CTD
PMID:16526316
NCBI chr10:86,616,785...86,619,160
Ensembl chr10:86,616,785...86,619,157
G
Dapk2
death-associated protein kinase 2
affects expression
EXP
Furosemide affects the expression of DAPK2 mRNA
CTD
PMID:17497460
NCBI chr 8:71,822,107...71,941,941
Ensembl chr 8:71,822,129...71,941,910
G
Ddit3
DNA-damage inducible transcript 3
increases expression
ISO
Furosemide results in increased expression of DDIT3 mRNA
CTD
PMID:24813929
NCBI chr 7:70,578,564...70,585,074
Ensembl chr 7:70,580,198...70,585,084
G
Dffa
DNA fragmentation factor subunit alpha
affects expression
EXP
Furosemide affects the expression of DFFA mRNA
CTD
PMID:17497460
NCBI chr 5:165,922,893...165,935,822
Ensembl chr 5:165,922,915...165,935,821
G
Efna5
ephrin A5
increases expression
EXP
Furosemide results in increased expression of EFNA5 mRNA
CTD
PMID:16526316
NCBI chr 9:110,054,002...110,329,878
Ensembl chr 9:110,057,155...110,225,486
G
Fadd
Fas associated via death domain
affects expression
EXP
Furosemide affects the expression of FADD mRNA
CTD
PMID:17497460
NCBI chr 1:217,746,176...217,748,581
Ensembl chr 1:217,742,929...217,748,628
G
Faslg
Fas ligand
affects expression
EXP
Furosemide affects the expression of FASLG mRNA
CTD
PMID:17497460
NCBI chr13:79,696,811...79,717,581
Ensembl chr13:79,698,445...79,705,705
G
Fgf16
fibroblast growth factor 16
affects expression
EXP
Furosemide affects the expression of FGF16 mRNA
CTD
PMID:16526316
NCBI chr X:76,786,728...76,796,311
Ensembl chr X:76,786,466...76,797,069
G
Fgf2
fibroblast growth factor 2
decreases expression
EXP
Furosemide results in decreased expression of FGF2 mRNA
CTD
PMID:16526316
NCBI chr 2:124,081,072...124,134,133
Ensembl chr 2:124,081,072...124,134,681
G
Fgf4
fibroblast growth factor 4
increases expression
EXP
Furosemide results in increased expression of FGF4 mRNA
CTD
PMID:16526316
NCBI chr 1:218,024,537...218,029,539
Ensembl chr 1:218,025,810...218,027,220
G
Fgfr4
fibroblast growth factor receptor 4
affects expression
EXP
Furosemide affects the expression of FGFR4 mRNA
CTD
PMID:16526316
NCBI chr17:9,990,072...10,004,339
Ensembl chr17:9,990,078...10,004,321
G
Flt1
Fms related receptor tyrosine kinase 1
increases expression
EXP
Furosemide results in increased expression of FLT1 mRNA
CTD
PMID:16526316
NCBI chr12:9,033,993...9,205,886
Ensembl chr12:9,034,308...9,205,905
G
Fos
Fos proto-oncogene, AP-1 transcription factor subunit
increases expression multiple interactions
ISO EXP
Furosemide results in increased expression of FOS protein Losartan inhibits the reaction [Furosemide results in increased expression of FOS protein]
CTD
PMID:10760498 PMID:15528393
NCBI chr 6:109,300,433...109,303,299
Ensembl chr 6:109,300,433...109,303,299
G
G6pd
glucose-6-phosphate dehydrogenase
decreases activity
EXP
Furosemide results in decreased activity of G6PD protein
CTD
PMID:26820767
NCBI chr X:156,274,800...156,293,935
Ensembl chr X:156,274,800...156,293,926
G
Gabra4
gamma-aminobutyric acid type A receptor subunit alpha 4
decreases activity
EXP
Furosemide results in decreased activity of GABRA4 protein
CTD
PMID:15613639
NCBI chr14:39,154,072...39,230,994
Ensembl chr14:39,154,529...39,231,695
G
Gad1
glutamate decarboxylase 1
decreases expression
EXP
Furosemide results in decreased expression of GAD1 mRNA
CTD
PMID:14596865
NCBI chr 3:56,861,440...56,902,139
Ensembl chr 3:56,861,396...56,902,157
G
Gadd45a
growth arrest and DNA-damage-inducible, alpha
affects expression
EXP
Furosemide affects the expression of GADD45A mRNA
CTD
PMID:17497460
NCBI chr 4:97,782,512...97,784,814
Ensembl chr 4:97,782,512...97,784,842
G
Gclm
glutamate cysteine ligase, modifier subunit
multiple interactions
EXP
[Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in decreased expression of GCLM mRNA; [Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in decreased expression of GCLM mRNA
CTD
PMID:29860548
NCBI chr 2:225,827,504...225,847,876
Ensembl chr 2:225,827,504...225,847,874
G
Gsr
glutathione-disulfide reductase
decreases activity
EXP
Furosemide results in decreased activity of GSR protein
CTD
PMID:26820767
NCBI chr16:62,197,617...62,239,987
Ensembl chr16:62,197,617...62,241,361
G
Hmgb1
high mobility group box 1
multiple interactions
EXP
[Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in increased expression of HMGB1 protein; [Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in increased expression of HMGB1 protein
CTD
PMID:29860548
NCBI chr12:7,082,529...7,090,246
Ensembl chr16:37,500,017...37,502,237
G
Hmox1
heme oxygenase 1
increases expression multiple interactions
ISO EXP
Furosemide results in increased expression of HMOX1 mRNA [Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in increased expression of HMOX1 mRNA; [Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in increased expression of HMOX1 mRNA
CTD
PMID:24813929 PMID:29860548
NCBI chr19:14,508,634...14,515,455
Ensembl chr19:14,508,616...14,515,456
G
Hrk
harakiri, BCL2 interacting protein
affects expression
EXP
Furosemide affects the expression of HRK mRNA
CTD
PMID:17497460
NCBI chr12:44,008,879...44,029,211
G
Hsd11b1
hydroxysteroid 11-beta dehydrogenase 1
decreases activity
EXP
Furosemide results in decreased activity of HSD11B1 protein
CTD
PMID:11749789
NCBI chr13:111,946,626...111,996,536
Ensembl chr13:111,926,442...111,972,603
G
Hus1
HUS1 checkpoint clamp component
affects expression
EXP
Furosemide affects the expression of HUS1 mRNA
CTD
PMID:17497460
NCBI chr14:89,194,086...89,208,825
Ensembl chr14:89,194,092...89,208,825
G
Id1
inhibitor of DNA binding 1, HLH protein
decreases expression
EXP
Furosemide results in decreased expression of ID1 mRNA
CTD
PMID:16526316
NCBI chr 3:148,214,623...148,216,715
Ensembl chr 3:148,215,540...148,216,718
G
Id3
inhibitor of DNA binding 3, HLH protein
decreases expression
EXP
Furosemide results in decreased expression of ID3 mRNA
CTD
PMID:16526316
NCBI chr 5:154,489,603...154,491,172
Ensembl chr 5:154,489,590...154,491,223
G
Ifna1
interferon, alpha 1
increases expression
EXP
Furosemide results in increased expression of IFNA1 mRNA
CTD
PMID:16526316
NCBI chr 5:106,951,822...106,952,908
Ensembl chr 5:106,952,082...106,952,792
G
Igf1
insulin-like growth factor 1
increases expression
EXP
Furosemide results in increased expression of IGF1 mRNA
CTD
PMID:16526316
NCBI chr 7:28,412,123...28,491,815
Ensembl chr 7:28,412,198...28,486,609
G
Il10
interleukin 10
decreases secretion
ISO
Furosemide results in decreased secretion of IL10 protein
CTD
PMID:16612254
NCBI chr13:47,738,933...47,743,392
Ensembl chr13:47,739,526...47,743,392
G
Il6
interleukin 6
decreases secretion
ISO
Furosemide results in decreased secretion of IL6 protein
CTD
PMID:16612254
NCBI chr 4:3,043,231...3,047,807
Ensembl chr 4:3,043,231...3,047,807
G
Itga5
integrin subunit alpha 5
decreases expression
EXP
Furosemide results in decreased expression of ITGA5 mRNA
CTD
PMID:16526316
NCBI chr 7:144,970,444...144,993,652
Ensembl chr 7:144,970,444...144,993,652
G
Kdr
kinase insert domain receptor
increases expression
EXP
Furosemide results in increased expression of KDR mRNA
CTD
PMID:16526316
NCBI chr14:34,727,677...34,787,127
Ensembl chr14:34,727,623...34,787,183
G
Lta
lymphotoxin alpha
affects expression
EXP
Furosemide affects the expression of LTA mRNA
CTD
PMID:17497460
NCBI chr20:4,851,889...4,854,677
Ensembl chr20:4,852,496...4,854,677
G
Ltb
lymphotoxin beta
affects expression
EXP
Furosemide affects the expression of LTB mRNA
CTD
PMID:17497460
NCBI chr20:5,184,631...5,186,476
Ensembl chr20:5,184,515...5,186,503
G
Ltbr
lymphotoxin beta receptor
affects expression
EXP
Furosemide affects the expression of LTBR mRNA
CTD
PMID:17497460
NCBI chr 4:157,822,838...157,829,291
Ensembl chr 4:157,822,840...157,829,241
G
Mdk
midkine
increases expression
EXP
Furosemide results in increased expression of MDK mRNA
CTD
PMID:16526316
NCBI chr 3:80,841,003...80,843,895
Ensembl chr 3:80,841,005...80,842,916
G
Mdm2
MDM2 proto-oncogene
affects expression
EXP
Furosemide affects the expression of MDM2 mRNA
CTD
PMID:17497460
NCBI chr 7:60,719,060...60,743,618
Ensembl chr 7:60,719,066...60,743,328
G
Msr1
macrophage scavenger receptor 1
increases expression
EXP
Furosemide results in increased expression of MSR1 mRNA
CTD
PMID:16526316
NCBI chr16:56,817,714...56,900,025
Ensembl chr16:56,813,791...56,900,052
G
Mt1
metallothionein 1
increases expression
ISO
Furosemide results in increased expression of MT1 mRNA
CTD
PMID:24813929
NCBI chr19:11,301,991...11,303,007
Ensembl chr17:78,793,336...78,793,724
G
Naip6
NLR family, apoptosis inhibitory protein 6
affects expression
EXP
Furosemide affects the expression of NAIP2 mRNA
CTD
PMID:17497460
NCBI chr 2:30,377,505...30,418,578
G
Nfe2l2
nuclear factor, erythroid 2-like 2
increases localization decreases response to substance
ISO
Furosemide results in increased localization of NFE2L2 protein NFE2L2 protein results in decreased susceptibility to Furosemide
CTD
PMID:18078705 PMID:24813929
NCBI chr 3:62,497,568...62,525,146
Ensembl chr 3:62,497,571...62,524,996
G
Nlrp3
NLR family, pyrin domain containing 3
multiple interactions
EXP
[Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in increased expression of NLRP3 protein
CTD
PMID:29860548
NCBI chr10:45,884,324...45,918,290
Ensembl chr10:45,893,018...45,918,254
G
Nol3
nucleolar protein 3
affects expression
EXP
Furosemide affects the expression of NOL3 mRNA
CTD
PMID:17497460
NCBI chr19:37,232,567...37,236,668
Ensembl chr19:37,235,001...37,236,649
G
Nos3
nitric oxide synthase 3
affects expression
EXP
Furosemide affects the expression of NOS3 mRNA
CTD
PMID:16526316
NCBI chr 4:7,321,908...7,342,404
Ensembl chr 4:7,320,668...7,342,410
G
Nppa
natriuretic peptide A
decreases expression
ISO
Furosemide results in decreased expression of NPPA protein
CTD
PMID:2146706
NCBI chr 5:164,808,407...164,809,716
Ensembl chr 5:164,808,323...164,809,705
G
Nqo1
NAD(P)H quinone dehydrogenase 1
multiple interactions
EXP
[Drinking Water deficiency co-treated with Furosemide co-treated with Iohexol] results in decreased expression of NQO1 mRNA
CTD
PMID:29860548
NCBI chr19:38,422,210...38,437,103
Ensembl chr19:38,422,164...38,437,180
G
Pdgfra
platelet derived growth factor receptor alpha
affects expression
EXP
Furosemide affects the expression of PDGFRA mRNA
CTD
PMID:16526316
NCBI chr14:35,527,926...35,581,130
Ensembl chr14:35,527,927...35,581,031
G
Pdgfrb
platelet derived growth factor receptor beta
increases expression
EXP
Furosemide results in increased expression of PDGFRB mRNA
CTD
PMID:16526316
NCBI chr18:56,364,586...56,406,381
Ensembl chr18:56,364,620...56,406,381
G
Pecam1
platelet and endothelial cell adhesion molecule 1
increases expression
EXP
Furosemide results in increased expression of PECAM1 mRNA
CTD
PMID:16526316
NCBI chr10:94,850,971...94,913,202
G
Pf4
platelet factor 4
decreases expression
EXP
Furosemide results in decreased expression of PF4 mRNA
CTD
PMID:16526316
NCBI chr14:18,848,549...18,849,258
Ensembl chr14:18,848,549...18,849,258
G
Pgd
phosphogluconate dehydrogenase
decreases activity
EXP
Furosemide results in decreased activity of PGD protein
CTD
PMID:26820767
NCBI chr 5:165,966,128...165,982,327
G
Pgf
placental growth factor
decreases expression
EXP
Furosemide results in decreased expression of PGF mRNA
CTD
PMID:16526316
NCBI chr 6:108,994,016...109,004,598
Ensembl chr 6:108,994,018...109,004,598
G
Pink1
PTEN induced kinase 1
multiple interactions
EXP
[Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in increased expression of PINK1 protein
CTD
PMID:29860548
NCBI chr 5:156,677,146...156,689,258
Ensembl chr 5:156,677,146...156,689,415
G
Prkn
parkin RBR E3 ubiquitin protein ligase
multiple interactions
EXP
[Drinking Water deficiency co-treated with Furosemide co-treated with iodixanol] results in increased expression of PRKN protein
CTD
PMID:29860548
NCBI chr 1:48,880,015...50,069,998
G
Ptger4
prostaglandin E receptor 4
multiple interactions
ISO
PTGER4 protein affects the reaction [Furosemide results in increased expression of REN mRNA]; PTGER4 protein affects the reaction [Furosemide results in increased expression of REN protein]
CTD
PMID:15976003
NCBI chr 2:54,951,625...54,966,470
Ensembl chr 2:54,952,821...54,963,448
G
Ptgs1
prostaglandin-endoperoxide synthase 1
affects expression
EXP
Furosemide affects the expression of PTGS1 mRNA; Furosemide affects the expression of PTGS1 protein
CTD
PMID:11961000
NCBI chr 3:15,560,685...15,582,339
Ensembl chr 3:15,560,712...15,582,344
G
Ptgs2
prostaglandin-endoperoxide synthase 2
affects expression multiple interactions increases expression
EXP
Furosemide affects the expression of PTGS2 mRNA; Furosemide affects the expression of PTGS2 protein [Furosemide results in increased expression of PTGS2 mRNA] which results in increased abundance of Prostaglandins; [rofecoxib results in decreased activity of PTGS2 protein] inhibits the reaction [Furosemide results in increased abundance of Prostaglandins] Furosemide results in increased expression of PTGS2 mRNA; Furosemide results in increased expression of PTGS2 protein
CTD
PMID:11135058 PMID:11703585 PMID:11961000 PMID:19031110
NCBI chr13:67,351,230...67,356,920
Ensembl chr13:67,351,087...67,359,335
G
Pth
parathyroid hormone
increases expression multiple interactions
EXP
Furosemide results in increased expression of PTH protein NPS R-467 inhibits the reaction [Furosemide results in increased expression of PTH protein]
CTD
PMID:15086907
NCBI chr 1:178,215,829...178,218,761
Ensembl chr 1:178,215,829...178,218,761
G
Ptn
pleiotrophin
affects expression
EXP
Furosemide affects the expression of PTN mRNA
CTD
PMID:16526316
NCBI chr 4:64,239,156...64,330,996
Ensembl chr 4:64,239,158...64,330,996
G
Ren
renin
multiple interactions increases expression increases secretion increases activity
ISO EXP
Furosemide inhibits the reaction [Ethinyl Estradiol results in increased expression of REN protein]; Indomethacin inhibits the reaction [Furosemide results in increased expression of REN protein]; Ketoprofen inhibits the reaction [Furosemide results in increased activity of REN protein]; Sulindac inhibits the reaction [Furosemide results in increased expression of REN protein] Furosemide results in increased secretion of REN protein Furosemide results in increased expression of REN mRNA; Furosemide results in increased expression of REN protein PTGER4 protein affects the reaction [Furosemide results in increased expression of REN mRNA]; PTGER4 protein affects the reaction [Furosemide results in increased expression of REN protein]
CTD
PMID:599795 PMID:1924052 PMID:3530574 PMID:4028619 PMID:7954537 PMID:8418022 PMID:10604960 PMID:11046100 PMID:11095476 PMID:11135058 PMID:15976003
NCBI chr13:50,502,724...50,513,953
Ensembl chr13:50,502,724...50,514,151
G
Ripk1
receptor interacting serine/threonine kinase 1
affects expression
EXP
Furosemide affects the expression of RIPK1 mRNA
CTD
PMID:17497460
NCBI chr17:31,537,580...31,569,904
Ensembl chr17:31,537,591...31,569,904
G
Rpa3
replication protein A3
affects expression
EXP
Furosemide affects the expression of RPA3 mRNA
CTD
PMID:17497460
NCBI chr 4:34,279,320...34,282,351
Ensembl chr 4:34,279,320...34,282,351
G
S100b
S100 calcium binding protein B
multiple interactions
EXP
[Furosemide results in decreased activity of SLC12A2 protein] affects the reaction [Thioctic Acid inhibits the reaction [Ammonia results in increased secretion of S100B protein]]; [Furosemide results in decreased activity of SLC12A2 protein] inhibits the reaction [Ammonia results in increased secretion of S100B protein]
CTD
PMID:23880158
NCBI chr20:13,130,633...13,142,856
Ensembl chr20:13,130,636...13,142,856
G
S100g
S100 calcium binding protein G
affects expression
ISO
Furosemide affects the expression of S100G mRNA
CTD
PMID:17652376
NCBI chr X:33,442,820...33,445,714
Ensembl chr X:33,443,186...33,445,709
G
S1pr1
sphingosine-1-phosphate receptor 1
increases expression
EXP
Furosemide results in increased expression of S1PR1 mRNA
CTD
PMID:16526316
NCBI chr 2:218,654,406...218,658,761
Ensembl chr 2:218,654,554...218,658,761
G
Serpinb5
serpin family B member 5
increases expression
EXP
Furosemide results in increased expression of SERPINB5 mRNA
CTD
PMID:16526316
NCBI chr13:26,903,052...26,923,250
Ensembl chr13:26,903,052...26,923,250
G
Serpinf1
serpin family F member 1
affects expression
EXP
Furosemide affects the expression of SERPINF1 mRNA
CTD
PMID:16526316
NCBI chr10:62,241,750...62,254,145
Ensembl chr10:62,241,756...62,254,287
G
Slc12a1
solute carrier family 12 member 1
decreases activity
ISO
Furosemide results in decreased activity of SLC12A1 protein
CTD
PMID:11249848
NCBI chr 3:117,421,531...117,498,372
Ensembl chr 3:117,421,604...117,498,367
G
Slc12a2
solute carrier family 12 member 2
multiple interactions decreases activity
EXP ISO
[Furosemide results in decreased activity of SLC12A2 protein] affects the reaction [Thioctic Acid inhibits the reaction [Ammonia results in increased secretion of S100B protein]]; [Furosemide results in decreased activity of SLC12A2 protein] inhibits the reaction [Ammonia results in increased secretion of S100B protein]; [Furosemide results in decreased activity of SLC12A2 protein] promotes the reaction [Thioctic Acid results in decreased activity of Ammonia]; [Furosemide results in decreased activity of SLC12A2 protein] which results in decreased susceptibility to Ammonia; [Furosemide results in decreased activity of SLC12A2 protein] which results in increased activity of Ammonia Furosemide inhibits the reaction [SLC12A2 protein results in increased uptake of Rubidium]
CTD
PMID:23880158 PMID:29959396
NCBI chr18:52,917,124...52,985,281
Ensembl chr18:52,917,124...52,985,261
G
Slc12a5
solute carrier family 12 member 5
decreases activity multiple interactions
EXP ISO
Furosemide results in decreased activity of SLC12A5 protein Furosemide inhibits the reaction [SLC12A5 protein results in increased import of Thallium]
CTD
PMID:18094240 PMID:20086212
NCBI chr 3:161,433,303...161,465,078
Ensembl chr 3:161,425,988...161,462,879
G
Slc12a7
solute carrier family 12 member 7
decreases activity
ISO
Furosemide results in decreased activity of SLC12A7 protein
CTD
PMID:10913127
NCBI chr 1:32,086,755...32,167,950
Ensembl chr 1:32,086,755...32,141,036
G
Slc22a6
solute carrier family 22 member 6
increases expression increases secretion decreases activity
EXP ISO
Furosemide results in increased expression of SLC22A6 protein SLC22A6 protein results in increased secretion of Furosemide Furosemide results in decreased activity of SLC22A6 protein
CTD
PMID:12897087 PMID:18216144
NCBI chr 1:224,824,809...224,833,284
Ensembl chr 1:224,824,799...224,833,259
G
Slc22a7
solute carrier family 22 member 7
multiple interactions
ISO
Furosemide inhibits the reaction [SLC22A7 protein results in increased transport of Tetracycline]
CTD
PMID:15901346
NCBI chr 9:16,925,321...16,931,119
Ensembl chr 9:16,924,520...16,931,766
G
Slc22a8
solute carrier family 22 member 8
decreases activity multiple interactions increases secretion
ISO EXP
Furosemide results in decreased activity of SLC22A8 protein Furosemide inhibits the reaction [SLC22A8 protein affects the transport of estrone sulfate] Furosemide inhibits the reaction [SLC22A8 protein results in increased uptake of estrone sulfate] SLC22A8 protein results in increased secretion of Furosemide
CTD
PMID:10224140 PMID:11306713 PMID:18216144
NCBI chr 1:224,799,444...224,818,482
Ensembl chr 1:224,800,252...224,818,482
G
Slc26a4
solute carrier family 26 member 4
multiple interactions affects localization
EXP
[Furosemide co-treated with Amiloride] affects the localization of SLC26A4 protein Furosemide affects the localization of SLC26A4 protein
CTD
PMID:17311909
NCBI chr 6:50,809,103...50,848,443
Ensembl chr 6:50,808,923...50,846,965
G
Sparc
secreted protein acidic and cysteine rich
increases expression
EXP
Furosemide results in increased expression of SPARC mRNA
CTD
PMID:16526316
NCBI chr10:40,742,390...40,764,232
Ensembl chr10:40,742,400...40,764,185
G
Spink1
serine peptidase inhibitor, Kazal type 1
increases expression
EXP
Furosemide results in increased expression of SPINK1 mRNA
CTD
PMID:28138970
NCBI chr18:38,221,919...38,242,092
Ensembl chr18:38,221,681...38,242,119
G
Sqstm1
sequestosome 1
multiple interactions
EXP
[Drinking Water deficiency co-treated with Furosemide] results in increased expression of SQSTM1 protein; iodixanol inhibits the reaction [[Drinking Water deficiency co-treated with Furosemide] results in increased expression of SQSTM1 protein]; Iohexol inhibits the reaction [[Drinking Water deficiency co-treated with Furosemide] results in increased expression of SQSTM1 protein]
CTD
PMID:29860548
NCBI chr10:35,704,728...35,716,316
Ensembl chr10:35,704,730...35,716,294
G
Tek
TEK receptor tyrosine kinase
increases expression
EXP
Furosemide results in increased expression of TEK mRNA
CTD
PMID:16526316
NCBI chr 5:113,725,717...113,852,799
Ensembl chr 5:113,725,717...113,852,799
G
Tgfa
transforming growth factor alpha
increases expression
EXP
Furosemide results in increased expression of TGFA mRNA
CTD
PMID:16526316
NCBI chr 4:117,961,877...118,045,923
Ensembl chr 4:117,962,319...118,046,344
G
Tgfb1
transforming growth factor, beta 1
affects expression
EXP
Furosemide affects the expression of TGFB1 protein
CTD
PMID:18001696
NCBI chr 1:82,480,875...82,497,196
Ensembl chr 1:82,480,195...82,497,199
G
Tgfb2
transforming growth factor, beta 2
increases expression
EXP
Furosemide results in increased expression of TGFB2 mRNA
CTD
PMID:16526316
NCBI chr13:105,039,639...105,142,010
Ensembl chr13:105,039,853...105,141,030
G
Tgfbr1
transforming growth factor, beta receptor 1
increases expression
EXP
Furosemide results in increased expression of TGFBR1 mRNA
CTD
PMID:16526316
NCBI chr 5:63,056,071...63,119,635
Ensembl chr 5:63,050,758...63,119,635
G
Tgfbr2
transforming growth factor, beta receptor 2
increases expression
EXP
Furosemide results in increased expression of TGFBR2 mRNA
CTD
PMID:16526316
NCBI chr 8:124,310,288...124,399,345
Ensembl chr 8:124,312,754...124,399,494
G
Thbs1
thrombospondin 1
affects expression
EXP
Furosemide affects the expression of THBS1 mRNA
CTD
PMID:16526316
NCBI chr 3:109,862,120...109,873,466
Ensembl chr 3:109,862,117...109,873,466
G
Thbs2
thrombospondin 2
increases expression
EXP
Furosemide results in increased expression of THBS2 mRNA
CTD
PMID:16526316
NCBI chr 1:56,653,929...56,683,571
Ensembl chr 1:56,653,938...56,683,731
G
Thbs3
thrombospondin 3
affects expression
EXP
Furosemide affects the expression of THBS3 mRNA
CTD
PMID:16526316
NCBI chr 2:188,528,979...188,540,738
Ensembl chr 2:188,528,979...188,540,736
G
Thbs4
thrombospondin 4
affects expression
EXP
Furosemide affects the expression of THBS4 mRNA
CTD
PMID:16526316
NCBI chr 2:22,343,727...22,385,855
Ensembl chr 2:22,343,727...22,385,855
G
Tie1
tyrosine kinase with immunoglobulin-like and EGF-like domains 1
increases expression
EXP
Furosemide results in increased expression of TIE1 mRNA
CTD
PMID:16526316
NCBI chr 5:137,294,544...137,321,116
Ensembl chr 5:137,294,544...137,321,121
G
Timp2
TIMP metallopeptidase inhibitor 2
affects expression
EXP
Furosemide affects the expression of TIMP2 mRNA
CTD
PMID:16526316
NCBI chr10:107,338,465...107,386,072
Ensembl chr10:107,338,465...107,386,072
G
Tnf
tumor necrosis factor
decreases secretion affects expression
ISO EXP
Furosemide results in decreased secretion of TNF protein Furosemide affects the expression of TNF mRNA
CTD
PMID:16526316 PMID:16612254 PMID:17497460
NCBI chr20:5,189,382...5,192,000
Ensembl chr20:5,189,390...5,192,000
G
Tnfrsf11a
TNF receptor superfamily member 11A
affects expression
EXP
Furosemide affects the expression of TNFRSF11A mRNA
CTD
PMID:17497460
NCBI chr13:25,778,306...25,835,802
Ensembl chr13:25,778,317...25,835,957
G
Tnfrsf1a
TNF receptor superfamily member 1A
affects expression
EXP
Furosemide affects the expression of TNFRSF1A mRNA
CTD
PMID:17497460
NCBI chr 4:157,864,905...157,877,634
Ensembl chr 4:157,864,969...157,877,633
G
Tnfrsf1b
TNF receptor superfamily member 1B
affects expression
EXP
Furosemide affects the expression of TNFRSF1B mRNA
CTD
PMID:17497460
NCBI chr 5:163,136,390...163,167,299
Ensembl chr 5:163,136,390...163,167,299
G
Tnfrsf25
TNF receptor superfamily member 25
affects expression
EXP
Furosemide affects the expression of TNFRSF25 mRNA
CTD
PMID:17497460
NCBI chr 5:169,288,419...169,293,137
Ensembl chr 5:169,288,871...169,293,137
G
Tnfrsf8
TNF receptor superfamily member 8
affects expression
EXP
Furosemide affects the expression of TNFRSF8 mRNA
CTD
PMID:17497460
NCBI chr 5:163,186,349...163,231,578
Ensembl chr 5:163,186,349...163,231,578
G
Tnfrsf9
TNF receptor superfamily member 9
affects expression
EXP
Furosemide affects the expression of TNFRSF9 mRNA
CTD
PMID:17497460
NCBI chr 5:168,009,245...168,035,813
Ensembl chr 5:168,009,393...168,035,810
G
Tnfsf10
TNF superfamily member 10
affects expression
EXP
Furosemide affects the expression of TNFSF10 mRNA
CTD
PMID:17497460
NCBI chr 2:113,008,008...113,026,899
Ensembl chr 2:113,007,549...113,026,899
G
Tnfsf11
TNF superfamily member 11
affects expression
EXP
Furosemide affects the expression of TNFSF11 mRNA
CTD
PMID:17497460
NCBI chr15:60,482,527...60,512,704
Ensembl chr15:60,482,527...60,512,704
G
Tnfsf12
TNF superfamily member 12
affects expression
EXP
Furosemide affects the expression of TNFSF12 mRNA
CTD
PMID:17497460
NCBI chr10:56,290,780...56,300,137
Ensembl chr10:56,290,780...56,300,077
G
Tnfsf13
TNF superfamily member 13
affects expression
EXP
Furosemide affects the expression of TNFSF13 mRNA
CTD
PMID:17497460
NCBI chr10:56,286,964...56,290,680
Ensembl chr10:56,286,887...56,289,952
G
Tnfsf8
TNF superfamily member 8
affects expression
EXP
Furosemide affects the expression of TNFSF8 mRNA
CTD
PMID:17497460
NCBI chr 5:79,664,779...79,691,547
Ensembl chr 5:79,664,765...79,691,258
G
Tnfsf9
TNF superfamily member 9
affects expression
EXP
Furosemide affects the expression of TNFSF9 mRNA
CTD
PMID:17497460
NCBI chr 9:9,909,942...9,912,276
Ensembl chr 9:9,909,948...9,912,276
G
Tpmt
thiopurine S-methyltransferase
decreases activity
ISO
Furosemide results in decreased activity of TPMT protein
CTD
PMID:8866635
NCBI chr17:18,029,090...18,047,716
Ensembl chr17:18,029,124...18,047,714
G
Traf5
TNF receptor-associated factor 5
affects expression
EXP
Furosemide affects the expression of TRAF5 mRNA
CTD
PMID:17497460
NCBI chr13:110,758,556...110,801,871
Ensembl chr13:110,758,761...110,784,209
G
Traf6
TNF receptor associated factor 6
affects expression
EXP
Furosemide affects the expression of TRAF6 mRNA
CTD
PMID:17497460
NCBI chr 3:91,252,829...91,271,607
Ensembl chr 3:91,252,829...91,271,607
G
Trpv5
transient receptor potential cation channel, subfamily V, member 5
increases expression
ISO
Furosemide results in increased expression of TRPV5 mRNA; Furosemide results in increased expression of TRPV5 protein
CTD
PMID:17652376
NCBI chr 4:70,947,615...70,974,004
Ensembl chr 4:70,947,717...70,974,006
G
Trpv6
transient receptor potential cation channel, subfamily V, member 6
increases expression
ISO
Furosemide results in increased expression of TRPV6 mRNA
CTD
PMID:17652376
NCBI chr 4:70,918,631...70,934,291
Ensembl chr 4:70,918,632...70,934,295
G
Ugt1a1
UDP glucuronosyltransferase family 1 member A1
increases expression
ISO
Furosemide results in increased expression of UGT1A1 mRNA
CTD
PMID:18227147
NCBI chr 9:95,295,701...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Ugt1a2
UDP glucuronosyltransferase 1 family, polypeptide A2
increases glucuronidation
ISO
UGT1A3 protein results in increased glucuronidation of Furosemide
CTD
PMID:15117964
NCBI chr 9:95,285,592...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Ugt1a8
UDP glucuronosyltransferase family 1 member A8
increases glucuronidation
ISO
UGT1A8 protein results in increased glucuronidation of Furosemide
CTD
PMID:15117964
NCBI chr 9:95,221,474...95,302,822
Ensembl chr 9:95,161,157...95,302,822
G
Vcam1
vascular cell adhesion molecule 1
increases expression
EXP
Furosemide results in increased expression of VCAM1 mRNA
CTD
PMID:16526316
NCBI chr 2:219,071,193...219,090,931
Ensembl chr 2:219,071,193...219,097,619
G
Vegfa
vascular endothelial growth factor A
affects expression
EXP
Furosemide affects the expression of VEGFA mRNA
CTD
PMID:16526316
NCBI chr 9:17,340,341...17,355,681
Ensembl chr 9:17,340,341...17,355,681
G
Vegfc
vascular endothelial growth factor C
increases expression
EXP
Furosemide results in increased expression of VEGFC mRNA
CTD
PMID:16526316
NCBI chr16:40,440,371...40,555,178
Ensembl chr16:40,440,207...40,555,576
G
Xiap
X-linked inhibitor of apoptosis
affects expression
EXP
Furosemide affects the expression of XIAP mRNA
CTD
PMID:17497460
NCBI chr X:128,409,425...128,455,786
Ensembl chr X:128,409,472...128,453,000
Term paths to the root one shortest all shortest one longest all longest one shortest and longest all
Path 1
CHEBI ontology
19875
role
19825
chemical role
19339
donor
18471
Bronsted acid
18323
oxoacid
18273
carbon oxoacid
18152
carboxylic acid
18142
chlorocarboxylic acid
194
chlorobenzoic acid
169
2,3,5-trichlorobenzoic acid
0
2,3,6-TBA
0
2,3-dichlorobenzoic acid
0
2,4-dichloro-5-(2-furanylmethylsulfamoyl)benzoic acid
0
2,4-dichlorobenzoic acid +
0
2,5-dichlorobenzoic acid +
0
2,6-dichlorobenzoic acid +
0
2-amino-5-chlorobenzoic acid
0
3,4,5-trichlorobenzoic acid
0
3,4-dichlorobenzoic acid +
0
3,5-Dichloroorsellinic acid
0
3,5-Dichlorosalicylicacid
0
3,5-dichlorobenzoic acid
0
4,5-dichloro-2-[oxo-(8-quinolinylamino)methyl]benzoic acid
0
5-chloro-2-methylbenzoic acid
0
5-chlorosalicylic acid
0
Chloramben
0
furosemide
169
monochlorobenzoic acid +
0
Path 2
CHEBI ontology
19875
subatomic particle
19873
composite particle
19873
hadron
19873
baryon
19873
nucleon
19873
atomic nucleus
19873
atom
19873
main group element atom
19763
p-block element atom
19763
carbon group element atom
19668
carbon atom
19657
organic molecular entity
19657
organic group
18569
organic divalent group
18560
organodiyl group
18560
carbonyl group
18468
carbonyl compound
18468
carboxylic acid
18142
aromatic carboxylic acid
10919
benzoic acids
10888
chlorobenzoic acid
169
2,3,5-trichlorobenzoic acid
0
2,3,6-TBA
0
2,3-dichlorobenzoic acid
0
2,4-dichloro-5-(2-furanylmethylsulfamoyl)benzoic acid
0
2,4-dichlorobenzoic acid +
0
2,5-dichlorobenzoic acid +
0
2,6-dichlorobenzoic acid +
0
2-amino-5-chlorobenzoic acid
0
3,4,5-trichlorobenzoic acid
0
3,4-dichlorobenzoic acid +
0
3,5-Dichloroorsellinic acid
0
3,5-Dichlorosalicylicacid
0
3,5-dichlorobenzoic acid
0
4,5-dichloro-2-[oxo-(8-quinolinylamino)methyl]benzoic acid
0
5-chloro-2-methylbenzoic acid
0
5-chlorosalicylic acid
0
Chloramben
0
furosemide
169
monochlorobenzoic acid +
0